Some common heterocyclic compound, 1150566-27-0, name is Ethyl 6-chloroimidazo[1,2-b]pyridazine-3-carboxylate, molecular formula is C9H8ClN3O2, traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route. Formula: C9H8ClN3O2
To (2R)-2-(3-fluoro-5-(methylthio)phenyl)pyrrolidine _ (Preparation 9, 0.30mmol, 1.2 equiv.), ethyl 6-chloroimidazo[1 ,2-b]pyridazine-3-carboxylate (0.25mmol) and KF (2.8mmol, 11 equiv.) was added DMSO (2ml) and the reaction was heated at 130C. After overnight reaction the reaction mixture was cooled to rt. Water (10ml) and EtOAc (10 ml) were added and the layers partitioned. The organic layer was washed three times with brine (10ml), dried over Na2S04 and the solvent was removed under vacuum. The crude material containing the title compound was used without further purification. LCMS m/z = 401.1 [M+H]+
These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route 1150566-27-0, its application will become more common.
Reference:
Patent; BENEVOLENTAI BIO LIMITED; BROWN, Alan; GLEN, Angela; (115 pag.)WO2020/39209; (2020); A1;,
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics